Bibliography
- KONNO H, ABE J, KANEKO T et at Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer. jpn. J. Cancer Res. (2001) 92 (5):516–523.
- TURETSCHEK K, PREDA A, FLOYD E et al.: MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model. Ear. j Nucl. Med. Mol. Imaging (2003) 30(3):448–455.
- JAIN RK: Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat. Med. (2001) 7(9):987–989.
- BOUCHER Y, LEUNIG M, JAIN RK: Tumor angiogenesis and interstitial hypertension. Cancer Res. (1996) 56(18):4264–4266.
- GUCCIONE S, YANG YS, SHI G et al: Functional genomics guided with MR imaging: mouse tumor model study. Radiology (2003) 228(2):560–568.
- FERRARA N, GERBER H, LECOUTER J: The biology of VEGF and its receptors. Nat. Med. (2003) 9(6):669–676.
- MALIK AK, GERBER HP: Targeting VEGF ligands and receptors in cancer. Targets (2003) 2(2):48–57.
- INOUE M, HAGER JH, FERRARA N et al.: VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis. Cancer Cell (2002) 1(2):193–202.
- BERGERS G, BREKKEN R, McMAHON G et al: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell. Biol. (2000) 2(10):737–744.